DGKA and neoplasm: Indeed, DGKα is a major determinant of T cell anergy and together with enhanced DGKζ, makes tumor‐infiltrating CD8 and NK lymphocytes hyporesponsive by downmodulating DAG signaling to MAPK pathway.